rs60657820

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032043.3(BRIP1):​c.*2090G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 199,364 control chromosomes in the GnomAD database, including 14,460 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11484 hom., cov: 31)
Exomes 𝑓: 0.35 ( 2976 hom. )

Consequence

BRIP1
NM_032043.3 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.505

Publications

3 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 17-61681206-C-G is Benign according to our data. Variant chr17-61681206-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.499 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRIP1NM_032043.3 linkc.*2090G>C 3_prime_UTR_variant Exon 20 of 20 ENST00000259008.7 NP_114432.2 Q9BX63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRIP1ENST00000259008.7 linkc.*2090G>C 3_prime_UTR_variant Exon 20 of 20 1 NM_032043.3 ENSP00000259008.2 Q9BX63-1

Frequencies

GnomAD3 genomes
AF:
0.380
AC:
57556
AN:
151414
Hom.:
11465
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.505
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.315
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.485
Gnomad SAS
AF:
0.263
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.346
Gnomad OTH
AF:
0.378
GnomAD4 exome
AF:
0.347
AC:
16615
AN:
47830
Hom.:
2976
AF XY:
0.346
AC XY:
7671
AN XY:
22152
show subpopulations
African (AFR)
AF:
0.477
AC:
933
AN:
1958
American (AMR)
AF:
0.257
AC:
367
AN:
1430
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
955
AN:
3198
East Asian (EAS)
AF:
0.427
AC:
3222
AN:
7554
South Asian (SAS)
AF:
0.232
AC:
92
AN:
396
European-Finnish (FIN)
AF:
0.206
AC:
7
AN:
34
Middle Eastern (MID)
AF:
0.366
AC:
104
AN:
284
European-Non Finnish (NFE)
AF:
0.331
AC:
9611
AN:
29022
Other (OTH)
AF:
0.335
AC:
1324
AN:
3954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
455
910
1365
1820
2275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.380
AC:
57628
AN:
151534
Hom.:
11484
Cov.:
31
AF XY:
0.373
AC XY:
27611
AN XY:
74068
show subpopulations
African (AFR)
AF:
0.505
AC:
20832
AN:
41268
American (AMR)
AF:
0.315
AC:
4800
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1056
AN:
3466
East Asian (EAS)
AF:
0.485
AC:
2473
AN:
5094
South Asian (SAS)
AF:
0.263
AC:
1267
AN:
4818
European-Finnish (FIN)
AF:
0.242
AC:
2559
AN:
10558
Middle Eastern (MID)
AF:
0.469
AC:
135
AN:
288
European-Non Finnish (NFE)
AF:
0.346
AC:
23457
AN:
67796
Other (OTH)
AF:
0.381
AC:
801
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1723
3446
5169
6892
8615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.217
Hom.:
442
Bravo
AF:
0.394
Asia WGS
AF:
0.343
AC:
1191
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group J Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.8
DANN
Benign
0.39
PhyloP100
-0.51

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60657820; hg19: chr17-59758567; API